"If you were a university professor, you wouldn't call it a study," he said, "If you were a scientist you might say it was biased against REACH." Sean O'Sullivan, regulatory affairs manager for Swiss trading giant Glencore, said that the issue of stigmatisation was very real once substances appear on candidate lists of any kind, leading downstream purchasers to look elsewhere. "What if Boeing discovers a substance on a candidate list, without going through the decision making process? They will ultimately avoid them, regardless," he said.
Bayram Ankarali, general manager of Etimine described borates as "the salt of industry", and said that they were "irreplaceable in many uses". As such he said that the pressure to substitute imposed by REACH was both "disproportionate and ineffective".
© 2001-2024 Fundación Dialnet · Todos los derechos reservados